NASDAQ
CASI Pharmaceuticals, Inc. (CASI) has a current ratio of 1.09x as of Monday, May 25, 2026. This represents a 80.12% decrease compared to its 12-month average of 5.46x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.